Potential development of turmeric extract nanoparticles as a topical anti-inflammatory agent

Nyoman Suryawati , I Made Jawi

Nyoman Suryawati
Dermatology and Venereology Department, Faculty of Medicine, Universitas Udayana-Sanglah Hospital, Denpasar, Bali-Indonesia. Email:

I Made Jawi
Pharmacology Department, Faculty of Medicine, Universitas Udayana, Bali-Indonesia
Online First: October 21, 2020 | Cite this Article
Suryawati, N., Jawi, I. 2020. Potential development of turmeric extract nanoparticles as a topical anti-inflammatory agent. Bali Medical Journal 9(3): 573-578. DOI:10.15562/bmj.v9i3.2026

Turmeric is the most commonly studied herbal ingredient because it has antioxidant, anti-inflammatory, antimicrobial, and anticancer activity. Considering that most inflammatory skin diseases are localized, it is considered that the topical application of turmeric extract can be beneficial because it has a local effect on the skin. The topical application of turmeric extract has limitations because the active ingredient content of curcumin (CUR) has poor solubility in water, low absorption, and rapid elimination of metabolites, which results in low bioavailability of the drug. Recent studies have focused more on nanoparticle formulations that can improve the stability and bioavailability of CUR.


Marin E, Briceno M, George C. Method to Produce Curcumin Oil-in-Water Nanoemulsions as Templates for Drug Carriers. Journal of Biotechnology & Biomaterials. 2016;06:1–8.

Kurup VP, Barrios CS. Immunomodulatory effects of curcumin in allergy. Molecular Nutrition & Food Research. 2008;52(9):1031–9.

Strimpakos AS, Sharma RA. Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials. Antioxidants & Redox Signaling. 2008;10(3):511–46.

Cavaleri F. Presenting a New Standard Drug Model for Turmeric and Its Prized Extract, Curcumin. International Journal of Inflammation. 2018;2018:1–18.

Nisar T, Iqbal M, Raza A, Safdar M, Iftikhar F, Waheed M. Estimation of Total Phenolics and Free Radical Scavenging of Turmeric (Curcuma longa). Environ Sci. 2015;15:6.

Anwar H, Hussain G, Mustafa I. Antioxidants from Natural Sources. In: Shalaby E, Azzam GM, editors. Antioxidants in Foods and Its Applications [Internet]. InTech; 2018 [cited 2019 May 26]. Available from:

Rajsekhar P, Bharani R, Angel K, Ramachandran M, Rajsekhar. Curcumin Nanoparticles: A Therapeutic Review. Res J Pharm, Biol Chem Sci. 2015;6:1180–5.

Gera M, Sharma N, Ghosh M, Huynh DL, Lee SJ, Min T, et al. Nanoformulations of curcumin: an emerging paradigm for improved remedial application. Oncotarget [Internet]. 2017 Sep 12 [cited 2018 Sep 25];8(39). Available from:

Hu L, Man H, Elias PM, Man M-Q. Herbal medicines that benefit epidermal permeability barrier function. Dermatologica Sinica. 2015;33(2):90–5.

de Souza Ferreira SB, Bruschi ML. Improving the bioavailability of curcumin: is micro/nanoencapsulation the key? Therapeutic Delivery. 2019 Feb;10(2):83–6.

Shukla T, Upmanyu N, Agrawal M, Saraf S, Saraf S, Alexander A. Biomedical applications of microemulsion through dermal and transdermal route. Biomedicine & Pharmacotherapy. 2018;108:1477–94.

Danole A, Kothali B, Apte A, Kulkarni A, Khot V, Patil A. Nanoparticles: An Overview. American Journal of Pharmtech Research. 2015;5:1–31.

Roberts M, Mohammed Y, Pastore M, Namjoshi S, Yousef S, Alinaghi A, et al. Topical and cutaneous delivery using nanosystems. Journal of Controlled Release. 2017;247:86–105.

Benson HAE, Mohammed Y, Grice JE, Roberts MS. Formulation Effects on Topical Nanoparticle Penetration. In: Hamblin M, Avci P, Prow T, editors. Nanoscience in Dermatology [Internet]. Elsevier; 2016 [cited 2019 Sep 8]. p. 115–26. Available from:

Tomoda K, Makino K. Nanoparticles for transdermal drug delivery system (TDDS). In: Colloid and Interface Science in Pharmaceutical Research and Development [Internet]. Elsevier; 2014 [cited 2020 Mar 8]. p. 131–47. Available from:

Dhanasekaran HR, Sharma CP, Haridoss P. Drug delivery nanosystems—An introduction. In: Sharma, editor. Drug Delivery Nanosystems for Biomedical Applications [Internet]. Elsevier; 2018 [cited 2020 Jan 8]. p. 1–12. Available from:

Wu X, Guy RH. Applications of nanoparticles in topical drug delivery and in cosmetics. Journal of Drug Delivery Science and Technology. 2009;19(6):371–84.

Nastiti C, Ponto T, Abd E, Grice J, Benson H, Roberts M. Topical Nano and Microemulsions for Skin Delivery. Pharmaceutics. 2017;9(4):37.

Muller R, Staufenbiel S, Keck C. Lipid Nanoparticles (SLN, NLC) for innovative consumer care & household products. Household and Personal Care Today. 2014;9:18–24.

Zamarioli CM, Martins RM, Carvalho EC, Freitas LAP. Nanoparticles containing curcuminoids (Curcuma longa): development of topical delivery formulation. Revista Brasileira de Farmacognosia. 2015;25(1):53–60.

Lacatusu I, Badea N, Niculae G, Bordei N, Stan R, Meghea A. Lipid nanocarriers based on natural compounds: An evolving role in plant extract delivery: Lipid nanocarriers based on natural compounds. European Journal of Lipid Science and Technology. 2014;116(12):1708–17.

Laura V, Mattia F, Roberta G, Federico I, Emi D, Chiara T, et al. Potential of Curcumin in Skin Disorders. Nutrients. 2019;10;11(9):2169.

Ahmed SMU, Luo L, Namani A, Wang XJ, Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;1863(2):585–97.

Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Ramirez-Tortosa Mc. Curcumin and Health. Molecules. 2016;25;21(3):264.

Amin MN, Liza KF, Sarwar MdS, Ahmed J, Adnan MdT, Chowdhury MI, et al. Effect of lipid peroxidation, antioxidants, macro minerals and trace elements on eczema. Archives of Dermatological Research. 2015;307(7):617–23.

Kutlubay Z, Uzunçakmak T, Engin B, Tuzun Y. J Turk Acad Dermatol 2011; 5 (4): 1154r1. J Turk Acad Dermatol. 2011;5:1154.

Boyanapalli SSS, Paredes-Gonzalez X, Fuentes F, Zhang C, Guo Y, Pung D, et al. Nrf2 Knockout Attenuates the Anti-Inflammatory Effects of Phenethyl Isothiocyanate and Curcumin. Chemical Research in Toxicology. 2014;27(12):2036–43.

He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? Molecules. 2015;20(5):9183–213.

Deshmukh P, Unni S, Krishnappa G, Padmanabhan B. The Keap1–Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophysical Reviews. 2017;9(1):41–56.

Kahkhaie KR, Mirhosseini A, Aliabadi A, Mohammadi A, Mousavi MJ, Haftcheshmeh SM, et al. Curcumin: a modulator of inflammatory signaling pathways in the immune system. Inflammopharmacology. 2019;27(5):885–900.

Paulraj F, Abas F, H. Lajis N, Othman I, Naidu R. Molecular Pathways Modulated by Curcumin Analogue, Diarylpentanoids in Cancer. Biomolecules. 2019;9(7):270.

Lasar A, Marienfeld R, Wirth T, Baumann B. NF-KB: Critical regulators of inflammation and the immune response. In: Gossen M, Kaufmann J, Triezenberg S, editors. Transcription Factors Handbook of Experimental Pharmacology. Berlin, Heidelberg: Springer; 2004. p. 325–76.

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget [Internet]. 2018 [cited 2019 Dec 10];9(6). Available from:

Witkamp R, Monshouwer M. Signal transduction in inflammatory processes, current and future therapeutic targets: A mini review. Veterinary Quarterly. 2000;22(1):11–6.

Gowthamarajan K. Multiple Biological Actions of Curcumin in the Management of Diabetic Foot Ulcer Complications: A Systematic Review. Tropical Medicine & Surgery. 2015;03(01):1–6.

Jurenka J. Anti-inflammatory Properties of Curcumin, a Major Constituent of Curcuma longa: A Review of Preclinical and Clinical Research. Alternative Medicine Review. 2009;14:141–53.

Epstein J, Sanderson IR, MacDonald TT. Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. British Journal of Nutrition. 2010;103(11):1545–57.

Boroumand N, Samarghandian S, Hashemy SI. Immunomodulatory, anti-inflammatory, and antioxidant effects of curcumin. Journal of Herbmed Pharmacology. 2018;7(4):211–9.

González-Reyes S, Guzmán-Beltrán S, Medina-Campos ON, Pedraza-Chaverri J. Curcumin Pretreatment Induces Nrf2 and an Antioxidant Response and Prevents Hemin-Induced Toxicity in Primary Cultures of Cerebellar Granule Neurons of Rats. Oxidative Medicine and Cellular Longevity. 2013;2013:1–14.

Ghosh S, Banerjee S, Sil PC. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food and Chemical Toxicology. 2015;83:111–24.

Deng Y, Verron E, Rohanizadeh R. Molecular Mechanisms of Anti-metastatic Activity of Curcumin. Anticancer Research. 2016;36(11):5639–48.

Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, et al. Chronic diseases, inflammation, and spices: how are they linked? Journal of Translational Medicine. 2018;16:1–25.

Hommes DW. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut. 2003;52(1):144–51.

Shehzad A, Lee YS. Molecular mechanisms of curcumin action: Signal transduction. BioFactors. 2013;39(1):27–36.

Aggarwal B, Sundaram C, Malani N, Ichikawa H. Curcumin: The Indian solid gold. In: Aggarwal BB, Surh Y-J, Shishodia S, editors. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease [Internet]. Boston, MA: Springer US; 2007 [cited 2019 May 19]. p. 1–76. (Advances in experimental medicine and biology; vol. 595). Available from:

No Supplementary Material available for this article.
Article Views      : 0
PDF Downloads : 0